Kyoto University · Faculty of Medicine / Graduate School of Medicine · 助教

Research keywordsSARS-CoV-2・neutralizing nanobodies・Omicron tropism・HIV latency・APOBEC3D・adult T-cell leukemia・TMPRSS2 usage・infection bioluminescence

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Intratracheal trimerized nanobody cocktail protects against SARS-CoV-2 Omicron in mice2022 · 2022年04月22日
• Nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants2021 · 2021年10月26日
• [Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification].Rinsho Ketsueki.,
• Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.European journal of pharmacology,

• Official profile